News for 'drug quality'

USTR flags hurdles in medical device exports to India

USTR flags hurdles in medical device exports to India

Rediff.com2 Apr 2025

The USTR report, released just ahead of the US' April 2 deadline for implementing reciprocal tariffs, has also cited high tariffs and price caps, which have not increased in line with inflation, as key obstacles for US businesses.

Doctors not prescribing generic drugs to be penalised

Doctors not prescribing generic drugs to be penalised

Rediff.com13 Aug 2023

All doctors must prescribe generic drugs, failing which they will be penalised and even their license to practice may also be suspended for a period, according to the new regulations issued by the National Medical Commission (NMC).

GOOD News! No Drug Price Hike In 2024

GOOD News! No Drug Price Hike In 2024

Rediff.com6 Feb 2024

For the consumer, there would be practically no impact on prices of essential medicines this year.

Fake medicines worth Rs 6.6 crore seized in Kolkata

Fake medicines worth Rs 6.6 crore seized in Kolkata

Rediff.com1 Jan 2025

'Anti-cancer, anti-diabetic, and other drugs suspected to be spurious were seized from the raid carried out at the firm.'

NMC stays generic drugs rule for doctors, bar on endorsing drugs

NMC stays generic drugs rule for doctors, bar on endorsing drugs

Rediff.com24 Aug 2023

Members of the IMA and IPA had met Mansukh Mandaviya on Monday and expressed their concerns over the regulations.

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Indian pharma improves compliance with USFDA; fewer OAI cases in 2024

Rediff.com30 Dec 2024

Indian pharmaceutical companies have made major strides in adhering to stringent US Food and Drug Administration (USFDA) norms in 2024, with data suggesting a decline in the number of adverse classification outcomes of inspections across biologics, drugs, and devices. In 2023, the USFDA conducted 225 inspections, which led to 18 cases of Official Action Indicated (OAI) and 117 cases of Voluntary Action Indicated (VAI).

Checks On Drug-Making Units Begins

Checks On Drug-Making Units Begins

Rediff.com29 Dec 2022

The joint inspections is to ensure the safety, efficacy, and quality of drugs available in the country

India maintains high import duty on American goods: US report

India maintains high import duty on American goods: US report

Rediff.com1 Apr 2025

India maintains "high" import duties on a wide range of American goods such as agricultural items, drug formulations, and alcoholic beverages, besides imposing non-tariif barriers, a US report has said. A day before announcing reciprocal tariffs, the US Trade Representative (USTR) released the 2025 National Trade Estimate (NTE) Report on March 31.

Equity market volatility may persist; long-term outlook remains constructive: Experts

Equity market volatility may persist; long-term outlook remains constructive: Experts

Rediff.com3 Apr 2025

The heightened global uncertainty due to the US "reciprocal tariffs" on India may cause near-term corrections and market turbulence, but the long-term outlook remains constructive, market experts said on Thursday. The US has announced 27 per cent reciprocal tariffs on India, citing high import duties imposed by New Delhi on American goods.

Are Indian drugs safe? US doctors worried over quality

Are Indian drugs safe? US doctors worried over quality

Rediff.com18 Mar 2014

Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

Industry bodies seek safeguards against influx of Chinese goods

Industry bodies seek safeguards against influx of Chinese goods

Rediff.com26 Apr 2025

Various industry bodies have sought immediate government intervention through the imposition of anti-dumping duties, claiming India has seen a surge in imports of Chinese goods over the past two weeks.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

10 Medical Streams After Class 12

10 Medical Streams After Class 12

Rediff.com15 May 2025

While MBBS continues to be the most sought-after stream for medical aspirants, post pandemic, the demand for skilled nurses and physiotherapists are on the rise, notes Nayagam PP, career counsellor and founder of EduJob360.

MBA, LLB students among 9 held for drug trafficking in Noida

MBA, LLB students among 9 held for drug trafficking in Noida

Rediff.com27 Nov 2023

The arrests have been made by officials of Sector 126 police station as part of a crackdown on narcotics ordered by police commissioner Laxmi Singh, deputy commissioner of police (Noida) Harish Chander said.

India Inc holds breath for Trump's new tariffs to kick in

India Inc holds breath for Trump's new tariffs to kick in

Rediff.com27 Feb 2025

Industry insiders in India warn that any such move in the pharmaceutical sector could be counterproductive for the US as it may face increased drug shortages if tariffs are imposed on such imports.

This will Likely Shape the Future of Pharma Inc

This will Likely Shape the Future of Pharma Inc

Rediff.com8 Mar 2025

Indian pharmaceutical companies may have units abroad as part of "distributed manufacturing" across various locations, according to industry veterans. This may come about over the next five to 10 years.

Pharma companies fight fakes with smart packaging

Pharma companies fight fakes with smart packaging

Rediff.com10 Oct 2024

Indian pharmaceutical companies are stepping up their efforts to combat the problem of counterfeit drugs, employing a variety of strategies, from packaging innovations to engaging private investigation agencies. The stakes are high, as counterfeit medicines not only harm consumers but also tarnish the reputation of leading brands.

Empuraan Review: Return Of The King

Empuraan Review: Return Of The King

Rediff.com27 Mar 2025

L2: Empuraan is an ambitious sequel that is bigger, bolder and timid in equal measure, observes Arjun Menon.

India's Medtech Industry To Develop High-end Equipment

India's Medtech Industry To Develop High-end Equipment

Rediff.com17 Apr 2025

According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24 (FY24)

76 pharma firms raided, licences of 18 cancelled for manufacturing spurious drugs

76 pharma firms raided, licences of 18 cancelled for manufacturing spurious drugs

Rediff.com28 Mar 2023

In a major crackdown against the manufacture of substandard drugs, central and state regulators conducted joint inspections at 76 pharma companies and cancelled the licences of 18 of them for producing spurious and adulterated drugs, official sources said on Tuesday.

US Firms Back Trump's India Tariffs

US Firms Back Trump's India Tariffs

Rediff.com31 Mar 2025

Industry associations and companies in the United States, including the US Chamber of Commerce, Coalition of Services Industries and the iconic bike company Harley Davidson have called on the Donald Trump dispensation to push India to reduce tariffs, non-tariffs, and regulatory barriers to boost American exports.

Sklamberg on challenges the US drug regulator faces globally

Sklamberg on challenges the US drug regulator faces globally

Rediff.com19 Mar 2015

The US Food and Drug Administration (FDA) says it does not follow an India agenda.

Cipla deploys drones to fly in critical drugs

Cipla deploys drones to fly in critical drugs

Rediff.com27 Sep 2023

Drug major Cipla on Tuesday said it has launched drone-powered deliveries of critical medicines - cardiac, respiratory and other essential chronic therapies - to hospitals and pharmacies across Himachal Pradesh in partnership with Skype Air Mobility, a Gurugram-based drone delivery company. Cipla is the first among large Indian pharmaceutical companies to adopt drone-based deliveries to facilitate expedited supply to stockists in remote areas, it claimed. The Mumbai-based firm said the use of drones will support the on-time delivery of its medicines to chemists and clinics in remote areas, and minimise risks of affecting cold chain products due to temperature excursions.

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Anti-cancer drugs, antibiotics, vaccines set to become cheaper

Rediff.com13 Sep 2022

Anti-infectives like Ivermectin, Mupirocin and Meropenem have also been added to the list, taking the total drugs under it to 384.

'Zero-For-Zero Tariff Is Best Medicine For India'

'Zero-For-Zero Tariff Is Best Medicine For India'

Rediff.com21 Apr 2025

'No retaliatory tariffs now. You can retaliate after a few months.' 'Today, there is no need to retaliate because it is a question of long term benefits.'

Modi 3.0's Plans For Ayushman Bharat

Modi 3.0's Plans For Ayushman Bharat

Rediff.com12 Jun 2024

The Centre is considering a proposal on increasing coverage under the Ayushman Bharat scheme to Rs 10 lakh from the current Rs 5 lakh.

How 'Guru Gary' is using cricket to keep slum kids away from drugs

How 'Guru Gary' is using cricket to keep slum kids away from drugs

Rediff.com15 Feb 2024

Notorious for drugs and crime and afflicted by large-scale poverty, the Khayelitsha township in Cape Town is better known for being one of the biggest slums on the planet. But World Cup-winning coach Gary Kirsten is attempting to change the image for good through cricket.

Nigeria flags 2 India-made drugs as substandard, having toxins

Nigeria flags 2 India-made drugs as substandard, having toxins

Rediff.com20 Jun 2023

Oral paracetamol and another cough medicine manufactured by companies based in Mumbai and Punjab were found to be "sub-standard or found to be containing toxins", reports Sohini Das.

Trade generics growth to dent value expansion of domestic drug market

Trade generics growth to dent value expansion of domestic drug market

Rediff.com2 Jan 2024

Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis. According to a Kotak Institutional Equities analysis, 70-110 basis points (bps) annual dent is expected from trade generics and Jan Aushadhi on Indian Pharma Market (IPM) growth at least until FY27-28 (see chart). Trade generic medicines are those that are not pushed into the market through doctor promotions.

Budget 2025: Grassroot Level Implementation Is Necessary

Budget 2025: Grassroot Level Implementation Is Necessary

Rediff.com5 Feb 2025

Simplifying investment policies at the micro level and introducing a time-bound framework will be critical for India's growth targets, notes Krishna Ella.

'BJP Will Come To Power In Kerala In 2026'

'BJP Will Come To Power In Kerala In 2026'

Rediff.com10 Apr 2025

'In today's political spectrum, it is the Bharatiya Janata Party that always says, nation first.'

Tirupati laddu row: Govt to wait for FSSAI report before action

Tirupati laddu row: Govt to wait for FSSAI report before action

Rediff.com23 Sep 2024

Amid the ongoing controversy over Tirupati laddu, Consumer Affairs Secretary Nidhi Khare on Monday said her department will consider additional measures to monitor ghee quality in the market only after receiving the Food Safety and Standards Authority of India (FSSAI) report.

Cops bust drug making unit in UP; MDMA worth Rs 200 cr seized, 9 Africans held

Cops bust drug making unit in UP; MDMA worth Rs 200 cr seized, 9 Africans held

Rediff.com17 May 2023

The police were also taken by surprise with what they witnessed -- a sophisticated setup for creating the synthetic drug, intense intoxicating smell inside the compound and the foreigners geared up with high-quality face masks.

Why Aamir Got Married At 21

Why Aamir Got Married At 21

Rediff.com14 Mar 2025

'Reena stayed in the next building. We fell in love but had to meet secretly because her parents didn't approve of me.' 'I would always be afraid that her parents would get her married off to somebody else.'

Glenmark buys certain OTC drugs from Wockhardt in US

Glenmark buys certain OTC drugs from Wockhardt in US

Rediff.com28 Jun 2022

Glenmark Pharmaceuticals Ltd on Tuesday said it has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the US. The acquisition by the company's fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement. The company, however, did not disclose the financial details.

Idiopathic Pulmonary Fibrosis: What Killed Ustad Zakir Hussain

Idiopathic Pulmonary Fibrosis: What Killed Ustad Zakir Hussain

Rediff.com17 Dec 2024

'It's almost like the tissue of the lung has a cancer spreading to it, which is causing scarring and rapidly progresses.'

There will be no winner: Xi's warning to Trump

There will be no winner: Xi's warning to Trump

Rediff.com10 Dec 2024

Gearing up for Trump 2.0 era, Chinese President Xi Jinping on Tuesday cautioned there will be no winner in a tariff or tech wars between China and the United States and vowed that Beijing would firmly safeguard its interests.

CBI to probe fraud allegations in AAP's mohalla clinics in Delhi

CBI to probe fraud allegations in AAP's mohalla clinics in Delhi

Rediff.com5 Jan 2024

The CBI probe was ordered following a recommendation by Delhi Lt Governor V K Saxena on the matter in December last year.

NCB, Navy seize drugs worth Rs 2,000 crore off Gujarat coast

NCB, Navy seize drugs worth Rs 2,000 crore off Gujarat coast

Rediff.com12 Feb 2022

'In a joint operation carefully planned by the NCB and the Indian Navy in the high seas, NCB officials have successfully seized around 529 kg of very high quality of hashish, 234 kg of finest quality of crystal methamphetamine and some quantity of heroin,' the anti-drug agency said in a release.

India acts to repair reputation as drugs exporter

India acts to repair reputation as drugs exporter

Rediff.com7 May 2014

As part of the charm offensive, New Delhi has invited global regulators -- including the FDA -- to visit Indian production units to get first-hand evidence of measures taken to ensure the quality of locally manufactured generics.